Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does DOLUTEGRAVIR Cause Pathogen resistance? 586 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 586 reports of Pathogen resistance have been filed in association with DOLUTEGRAVIR (Juluca). This represents 5.4% of all adverse event reports for DOLUTEGRAVIR.

586
Reports of Pathogen resistance with DOLUTEGRAVIR
5.4%
of all DOLUTEGRAVIR reports
2
Deaths
13
Hospitalizations

How Dangerous Is Pathogen resistance From DOLUTEGRAVIR?

Of the 586 reports, 2 (0.3%) resulted in death, 13 (2.2%) required hospitalization.

Is Pathogen resistance Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for DOLUTEGRAVIR. However, 586 reports have been filed with the FAERS database.

What Other Side Effects Does DOLUTEGRAVIR Cause?

Foetal exposure during pregnancy (1,036) Exposure during pregnancy (776) Virologic failure (770) Maternal exposure during pregnancy (517) Viral mutation identified (510) Treatment failure (453) Drug ineffective (447) Off label use (413) Blood hiv rna increased (410) Treatment noncompliance (409)

What Other Drugs Cause Pathogen resistance?

LAMIVUDINE (1,733) TENOFOVIR DISOPROXIL (811) EFAVIRENZ (567) ZIDOVUDINE (552) RALTEGRAVIR (425) CLARITHROMYCIN (423) LEVOFLOXACIN (414) METRONIDAZOLE (404) CIPROFLOXACIN (377) VANCOMYCIN (372)

Which DOLUTEGRAVIR Alternatives Have Lower Pathogen resistance Risk?

DOLUTEGRAVIR vs DOLUTEGRAVIR\LAMIVUDINE DOLUTEGRAVIR vs DOLUTEGRAVIR\LAMIVUDINE\TENOFOVIR DISOPROXIL DOLUTEGRAVIR vs DOLUTEGRAVIR\RILPIVIRINE DOLUTEGRAVIR vs DOMPERIDONE DOLUTEGRAVIR vs DOMPERIDONE\PANTOPRAZOLE

Related Pages

DOLUTEGRAVIR Full Profile All Pathogen resistance Reports All Drugs Causing Pathogen resistance DOLUTEGRAVIR Demographics